Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DSS, INC.DSS · Entity 8811 | Interim CFO | October 28, 2020 | November 04, 2020 |
| IMPACT BIOMEDICAL INC.IBO · Entity 7209 | Chief Financial Officer | March 25, 2026 | March 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DSS, INC.
Report date October 28, 2020 · Filed November 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,667 |
Reported balance
Holding disclosure · report date 2020-10-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,667 |
IMPACT BIOMEDICAL INC.
Report date March 25, 2026 · Filed March 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 198,122 |
Reported balance
After 2026-03-25 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2026-03-25 · Sale · Disposed 1,600 · Balance 198,122 |
| Common StockSEC Table I · non-derivative | Direct | 155,122 |
Reported balance
After 2026-03-27 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2026-03-27 · Sale · Disposed 43,400 · Balance 155,122 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 27, 2026 Filed Mar 30, 2026 21:06 UTC | IMPACT BIOMEDICAL INC. IBO · Entity 7209 | SaleCommon Stock | 43,400 | $0.56 | $24,369.10 |
DisclosureSEC source: 0001493152-26-013708 · ownership.xml · nonDerivative · entry 2 Macko Todd D · CIK 0001830744 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,122 Read SEC document |
| March 25, 2026 Filed Mar 30, 2026 21:06 UTC | IMPACT BIOMEDICAL INC. IBO · Entity 7209 | SaleCommon Stock | 1,600 | $0.60 | $961.28 |
DisclosureSEC source: 0001493152-26-013708 · ownership.xml · nonDerivative · entry 1 Macko Todd D · CIK 0001830744 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,122 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.